170 related articles for article (PubMed ID: 25867971)
1. Levels of F2 isoprostane in Behcet's disease: Correlation with cardiometabolic risk factors.
Sagun G; Oguz A; Mesci B; Isbilen B; Kavala M; Keskin H; Takir M; Aydin SZ
Redox Rep; 2015 Sep; 20(5):223-7. PubMed ID: 25867971
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin levels, insulin resistance and their relationship with serum levels of inflammatory cytokines in patients with Behçet's disease.
Şahin E; Karaman G; Uslu M; Karul A; Şendur N; Şavk E
J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1498-502. PubMed ID: 22035239
[TBL] [Abstract][Full Text] [Related]
3. The relationship of oxidative stress, adiposity and metabolic risk factors in healthy Black and White American youth.
Warolin J; Coenen KR; Kantor JL; Whitaker LE; Wang L; Acra SA; Roberts LJ; Buchowski MS
Pediatr Obes; 2014 Feb; 9(1):43-52. PubMed ID: 23296459
[TBL] [Abstract][Full Text] [Related]
4. Increased F3-Isoprostanes in the Canadian Inuit Population Could Be Cardioprotective by Limiting F2-Isoprostane Production.
Alkazemi D; Jackson RL; Chan HM; Kubow S
J Clin Endocrinol Metab; 2016 Sep; 101(9):3264-71. PubMed ID: 27192695
[TBL] [Abstract][Full Text] [Related]
5. Elevated plasma F2-isoprostane levels in schizophrenia.
Lee EE; Eyler LT; Wolkowitz OM; Martin AS; Reuter C; Kraemer H; Jeste DV
Schizophr Res; 2016 Oct; 176(2-3):320-326. PubMed ID: 27318521
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin, visceral fat, oxidative stress, and early macrovascular disease: the Coronary Artery Risk Development in Young Adults Study.
Steffes MW; Gross MD; Lee DH; Schreiner PJ; Jacobs DR
Obesity (Silver Spring); 2006 Feb; 14(2):319-26. PubMed ID: 16571859
[TBL] [Abstract][Full Text] [Related]
7. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
8. Urine 8-isoprostane in relation to adiposity and insulin resistance in individuals at high cardiometabolic risk.
Costabile G; Della Pepa G; Bozzetto L; Annuzzi G; Vetrani C; Giacco R; Della Corte G; Conte FS; Di Marino L; Rivellese AA
Metab Syndr Relat Disord; 2015 May; 13(4):187-91. PubMed ID: 25714911
[TBL] [Abstract][Full Text] [Related]
9. F2-isoprostanes as a biomarker of oxidative stress in the mouse bladder.
Clayton DB; Stephany HA; Ching CB; Rahman SA; Tanaka ST; Thomas JC; Pope JC; Adams MC; Brock JW; Clark PE; Hayward SW; Matusik RJ; Milne GL
J Urol; 2014 May; 191(5 Suppl):1597-601. PubMed ID: 24679873
[TBL] [Abstract][Full Text] [Related]
10. Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients.
Ikizler TA; Morrow JD; Roberts LJ; Evanson JA; Becker B; Hakim RM; Shyr Y; Himmelfarb J
Clin Nephrol; 2002 Sep; 58(3):190-7. PubMed ID: 12356187
[TBL] [Abstract][Full Text] [Related]
11. Peripheral insulin resistance in patients with Behçet's disease.
Erdem H; Dinc A; Pay S; Simsek I; Turan M
J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):391-5. PubMed ID: 16643134
[TBL] [Abstract][Full Text] [Related]
12. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of alpha-1 acid glycoprotein and pentraxin 3 in patients with Behçet's disease and relationship with disease activity.
Yazmalar L; Batmaz İ; Sula B; Alpaycı M; Aydın F; Türkçü F; Yıldız M; Kaplan İ; Bozkurt M; Dağlı AZ; Burkan YK; Sarıyıldız MA
Int J Dermatol; 2015 Oct; 54(10):e394-400. PubMed ID: 26147939
[TBL] [Abstract][Full Text] [Related]
14. Oxidative Stress Biomarkers of Brain Damage: Hyperacute Plasma F2-Isoprostane Predicts Infarct Growth in Stroke.
Lorenzano S; Rost NS; Khan M; Li H; Lima FO; Maas MB; Green RE; Thankachan TK; Dipietro AJ; Arai K; Som AT; Pham LD; Wu O; Harris GJ; Lo EH; Blumberg JB; Milbury PE; Feske SK; Furie KL
Stroke; 2018 Mar; 49(3):630-637. PubMed ID: 29371434
[TBL] [Abstract][Full Text] [Related]
15. Aerobic training reduces systemic oxidative stress in young women with elevated levels of F2-isoprostanes.
Arikawa AY; Thomas W; Gross M; Smith A; Phipps WR; Kurzer MS; Schmitz KH
Contemp Clin Trials; 2013 Mar; 34(2):212-7. PubMed ID: 23178737
[TBL] [Abstract][Full Text] [Related]
16. Atherogenic lipid profile in Behçet's disease: evidence of alteration of HDL subclasses.
Messedi M; Jamoussi K; Frigui M; Laporte F; Turki M; Chaabouni K; Mnif E; Jaloulli M; Kaddour N; Bahloul Z; Ayedi F
Arch Med Res; 2011 Apr; 42(3):211-8. PubMed ID: 21722817
[TBL] [Abstract][Full Text] [Related]
17. Interaction between oxidative stress and high-density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis.
Rho YH; Chung CP; Oeser A; Solus JF; Gebretsadik T; Shintani A; Raggi P; Milne GL; Stein CM
Arthritis Care Res (Hoboken); 2010 Oct; 62(10):1473-80. PubMed ID: 20506360
[TBL] [Abstract][Full Text] [Related]
18. Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA.
Iuliano L; Praticò D; Greco C; Mangieri E; Scibilia G; FitzGerald GA; Violi F
J Am Coll Cardiol; 2001 Jan; 37(1):76-80. PubMed ID: 11153776
[TBL] [Abstract][Full Text] [Related]
19. F2-isoprostanes in kidney transplant patients: relationship with inflammatory markers.
Lauzurica R; Pastor MC; Bayés B; Hernández JM; Bonet J; Llopis MA; Carrera L; Romero R
Transplant Proc; 2005 Nov; 37(9):3842-3. PubMed ID: 16386558
[TBL] [Abstract][Full Text] [Related]
20. Elevated oxidative stress markers and its relationship with endothelial dysfunction in Behçet disease.
Acikgoz N; Ermiş N; Yağmur J; Cansel M; Karincaoğlu Y; Ataş H; Cuglan B; Barutcu I; Pekdemir H; Özdemir R
Angiology; 2011 May; 62(4):296-300. PubMed ID: 20947865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
